131 related articles for article (PubMed ID: 24355990)
1. Melanoma associated with the use of melanotan-II.
Hjuler KF; Lorentzen HF
Dermatology; 2014; 228(1):34-6. PubMed ID: 24355990
[TBL] [Abstract][Full Text] [Related]
2. Atypical melanocytic naevi following melanotan injection.
Reid C; Fitzgerald T; Fabre A; Kirby B
Ir Med J; 2013 May; 106(5):148-9. PubMed ID: 23914578
[TBL] [Abstract][Full Text] [Related]
3. Melanotan II User Experience: A Qualitative Study of Online Discussion Forums.
Gilhooley E; Daly S; McKenna D
Dermatology; 2021; 237(6):995-999. PubMed ID: 34464955
[TBL] [Abstract][Full Text] [Related]
4. Melanotan-associated melanoma in situ.
Ong S; Bowling J
Australas J Dermatol; 2012 Nov; 53(4):301-2. PubMed ID: 22724573
[TBL] [Abstract][Full Text] [Related]
5. An in-depth case examination of an exotic dancer's experience of melanotan.
Van Hout MC; Brennan R
Int J Drug Policy; 2014 May; 25(3):444-50. PubMed ID: 24280586
[TBL] [Abstract][Full Text] [Related]
6. alpha-Melanocyte-stimulating hormone-induced eruptive nevi.
Cardones AR; Grichnik JM
Arch Dermatol; 2009 Apr; 145(4):441-4. PubMed ID: 19380666
[TBL] [Abstract][Full Text] [Related]
7. Update on tanning: More risks, fewer benefits.
O'Leary RE; Diehl J; Levins PC
J Am Acad Dermatol; 2014 Mar; 70(3):562-8. PubMed ID: 24388421
[TBL] [Abstract][Full Text] [Related]
8. Melanotan-associated melanoma.
Paurobally D; Jason F; Dezfoulian B; Nikkels AF
Br J Dermatol; 2011 Jun; 164(6):1403-5. PubMed ID: 21564053
[No Abstract] [Full Text] [Related]
9. Risks of unregulated use of alpha-melanocyte-stimulating hormone analogues: a review.
Habbema L; Halk AB; Neumann M; Bergman W
Int J Dermatol; 2017 Oct; 56(10):975-980. PubMed ID: 28266027
[TBL] [Abstract][Full Text] [Related]
10. [Melanotan-induced lentigines and nevi].
Thestrup-Pedersen K; Søndergaard K
Ugeskr Laeger; 2011 Mar; 173(13):975. PubMed ID: 21453640
[TBL] [Abstract][Full Text] [Related]
11. Effects of a superpotent melanotropic peptide in combination with solar UV radiation on tanning of the skin in human volunteers.
Dorr RT; Ertl G; Levine N; Brooks C; Bangert JL; Powell MB; Humphrey S; Alberts DS
Arch Dermatol; 2004 Jul; 140(7):827-35. PubMed ID: 15262693
[TBL] [Abstract][Full Text] [Related]
12. Melanotan II injection resulting in systemic toxicity and rhabdomyolysis.
Nelson ME; Bryant SM; Aks SE
Clin Toxicol (Phila); 2012 Dec; 50(10):1169-73. PubMed ID: 23121206
[TBL] [Abstract][Full Text] [Related]
13. Eruptive naevi and darkening of pre-existing naevi 24 h after a single mono-dose injection of melanotan II.
Schulze F; Erdmann H; Hardkop LH; Anemüller W; Rose C; Zillikens D; Fischer TW
Eur J Dermatol; 2014; 24(1):107-9. PubMed ID: 24334249
[No Abstract] [Full Text] [Related]
14. A glimpse into the underground market of melanotan.
Callaghan Iii DJ
Dermatol Online J; 2018 May; 24(5):. PubMed ID: 30142729
[TBL] [Abstract][Full Text] [Related]
15. Hemodynamic actions and mechanisms of systemically administered α-MSH analogs in mice.
Rinne P; Tikka S; Mäkelä S; Streng T; Savontaus E
Peptides; 2012 Nov; 38(1):150-8. PubMed ID: 22982611
[TBL] [Abstract][Full Text] [Related]
16. The unregulated use of melanotan-II is of public health interest to Australian dermatologists.
Adler NR; Dowling JP; Pan Y
Australas J Dermatol; 2017 Nov; 58(4):327-329. PubMed ID: 28905366
[No Abstract] [Full Text] [Related]
17. Determination of melanotan-II in rat plasma by liquid chromatography/tandem mass spectrometry: determination of pharmacokinetic parameters in rat following intravenous administration.
Mock S; Shen X; Tamvakopoulos C
Rapid Commun Mass Spectrom; 2002; 16(22):2142-7. PubMed ID: 12415547
[TBL] [Abstract][Full Text] [Related]
18. Eruptive melanocytic naevi following melanotan injection.
Cousen P; Colver G; Helbling I
Br J Dermatol; 2009 Sep; 161(3):707-8. PubMed ID: 19575725
[No Abstract] [Full Text] [Related]
19. A liquid chromatographic/tandem mass spectroscopic method for quantification of the cyclic peptide melanotan-II. Plasma and brain tissue concentrations following administration in mice.
Hatziieremia S; Kostomitsopoulos N; Balafas V; Tamvakopoulos C
Rapid Commun Mass Spectrom; 2007; 21(15):2431-8. PubMed ID: 17610239
[TBL] [Abstract][Full Text] [Related]
20. [The Barbie drug melanotan--new internet drug with risky consequences].
Knudsen K; Kjergaard C; Dalhoff K
Lakartidningen; 2012 Oct 17-23; 109(42):1895-6. PubMed ID: 23193937
[No Abstract] [Full Text] [Related]
[Next] [New Search]
